ANDA 85621, held by KV Pharmaceutical. Diphenhydramine Hydrochloride.
As of Nov 22, 2026, ANDA 85621 (Diphenhydramine Hydrochloride), held by KV Pharmaceutical, was first approved by FDA on Sep 22, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 22, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diphenhydramine Hydrochloride12.5MG/5ML · elixir;oral | Diphenhydramine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters